Werewolf Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HOWL research report →
About the company
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity.
- CEO
- Daniel J. Hicklin
- IPO
- 2021
- Employees
- 46
- HQ
- Watertown, MA, US
Price Chart
- Market Cap
- $16.54M
- P/E
- -0.28
- P/S
- 0.00
- P/B
- 1.36
- EV/EBITDA
- -0.15
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -208.23%
- ROIC
- -103.43%
- Revenue
- $0 · -100.00%
- Net Income
- $-60,822,000 · 13.75%
- EPS
- $-1.32 · 19.02%
- Op Income
- $-60,677,000
- FCF YoY
- -6.82%
- 52W High
- $2.38
- 52W Low
- $0.27
- 50D MA
- $0.50
- 200D MA
- $0.89
- Beta
- 0.30
- Avg Volume
- 612.38K
Get TickerSpark's AI analysis on HOWL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | EVNIN LUKE | sell | 157,084 |
| Jun 17, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 389,216 |
| Jun 17, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 27,695 |
| Jun 12, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 159,119 |
| Jun 15, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 120,216 |
| Jun 16, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 139,686 |
| Jun 12, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 11,322 |
| Jun 15, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 8,554 |
| Jun 16, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 9,939 |
| Jun 9, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 345,235 |
Our HOWL coverage
Recent articles, reports, and earnings notes.
No research on HOWL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HOWL report →Similar companies
Peers in the same neighborhood.